Tabrizian, Parissa <br/><br/>
Renal Safety of Intravenous Ketorolac Use After Donor Nephrectomy.  [electronic resource] 

 -  Progress in transplantation (Aliso Viejo, Calif.)  09 2019 
 - 283-286 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2164-6708 
<br/><br/><label>Standard No.: </label>10.1177/1526924819855360  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravenous<br/>Adult<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Creatinine--blood<br/>Female<br/>Humans<br/>Ketorolac--therapeutic use<br/>Laparoscopy<br/>Length of Stay--statistics & numerical data<br/>Living Donors<br/>Male<br/>Middle Aged<br/>Nephrectomy<br/>Operative Time<br/>Pain, Postoperative--drug therapy<br/>Postoperative Complications--epidemiology<br/>Postoperative Hemorrhage--epidemiology<br/>Renal Insufficiency--epidemiology<br/>Retrospective Studies<br/>Warm Ischemia